About Cytrellis
Cytrellis is a company based in Boston (United States) founded in 2012.. Cytrellis has raised $111.22 million across 7 funding rounds from investors including Arch Venture Partners, PFM Health Sciences and Sands Capital Ventures. The company has 59 employees as of December 31, 2022. Cytrellis offers products and services including ellacor. Cytrellis operates in a competitive market with competitors including Clearanail, aesthetiCare, Procell Therapies, Dermapen World and Altair Instruments, among others.
- Headquarter Boston, United States
- Employees 59 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cytrellis Biosystems, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$111.22 M (USD)
in 7 rounds
-
Latest Funding Round
$25.13 M (USD), Series C
Dec 20, 2024
-
Investors
Arch Venture Partners
& 6 more
-
Employee Count
59
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cytrellis
Cytrellis offers a comprehensive portfolio of products and services, including ellacor. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
System for micro-scale removal of sagging skin.
Unlock access to complete
Unlock access to complete
Funding Insights of Cytrellis
Cytrellis has successfully raised a total of $111.22M across 7 strategic funding rounds. The most recent funding activity was a Series C round of $25.13 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Series C — $25.1M
-
First Round
First Round
(11 Dec 2012)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2024 | Amount | Series C - Cytrellis | Valuation |
investors |
|
| Jan, 2021 | Amount | Series C - Cytrellis | Valuation | Arch Venture Partners , PFM Health Sciences |
|
| Jun, 2018 | Amount | Series B - Cytrellis | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cytrellis
Cytrellis has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Arch Venture Partners, PFM Health Sciences and Sands Capital Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on life science companies
|
Founded Year | Domain | Location | |
|
Healthcare companies are invested in by this private equity firm.
|
Founded Year | Domain | Location | |
|
Growth stage tech & life sciences focused VC Firm investing in Asia and the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cytrellis
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cytrellis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cytrellis Comparisons
Competitors of Cytrellis
Cytrellis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Clearanail, aesthetiCare, Procell Therapies, Dermapen World and Altair Instruments, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Medical device for fungal nail treatment is developed.
|
|
| domain | founded_year | HQ Location |
Developer of tattoo removal pen
|
|
| domain | founded_year | HQ Location |
Microneedling and dermabrasion systems are developed for aesthetic procedures.
|
|
| domain | founded_year | HQ Location |
Micro needling products for treating skin conditions are developed.
|
|
| domain | founded_year | HQ Location |
Offers microdermabrasion machines, wands, and serums for professional skin treatments worldwide.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cytrellis
Frequently Asked Questions about Cytrellis
When was Cytrellis founded?
Cytrellis was founded in 2012.
Where is Cytrellis located?
Cytrellis is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Is Cytrellis a funded company?
Cytrellis is a funded company, having raised a total of $111.22M across 7 funding rounds to date. The company's 1st funding round was a Series B of $28.5M, raised on Dec 11, 2012.
How many employees does Cytrellis have?
As of Dec 31, 2022, the latest employee count at Cytrellis is 59.
What does Cytrellis do?
Cytrellis was founded in 2012 in Boston, United States, as a clinical-stage med-tech company focused on dermatology and aesthetic medicine. A proprietary class of devices is being developed to tighten and manipulate skin without surgery, while sagging skin linked to aging is addressed without incisions or scarring. Operations involve collaboration with physicians and partners to create solutions prioritizing safety, clinical outcomes, and enhanced quality of life for patients.
Who are the top competitors of Cytrellis?
Cytrellis's top competitors include Dermapen World, Clearanail and aesthetiCare.
What products or services does Cytrellis offer?
Cytrellis offers ellacor.
Who are Cytrellis's investors?
Cytrellis has 7 investors. Key investors include Arch Venture Partners, PFM Health Sciences, Sands Capital Ventures, PFM Health Sciences, and Merz.